Cross talk between stimulated NF-κB and the tumor suppressor p53

Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.

[1]  B. Nayak,et al.  Stabilization of p53 and transactivation of its target genes in response to replication blockade , 2002, Oncogene.

[2]  A. Nakagawara,et al.  ATM-dependent nuclear accumulation of IKK-α plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin , 2008, Oncogene.

[3]  David F. Kashatus,et al.  Expression of the Bcl-3 proto-oncogene suppresses p53 activation. , 2006, Genes & development.

[4]  G. Wahl,et al.  p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. , 2002, Cancer cell.

[5]  S. Miyamoto,et al.  Induction of a pro‐apoptotic ATM–NF‐κB pathway and its repression by ATR in response to replication stress , 2008, The EMBO journal.

[6]  J. Brüning,et al.  Riboflavin kinase couples TNF receptor 1 to NADPH oxidase , 2009, Nature.

[7]  S. Lowe,et al.  Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.

[8]  R. Nussinov,et al.  Protein-protein interaction networks: how can a hub protein bind so many different partners? , 2009, Trends in biochemical sciences.

[9]  A. Berns,et al.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.

[10]  M. Schmitz,et al.  Autoregulatory feedback loops terminating the NF-kappaB response. , 2009, Trends in biochemical sciences.

[11]  W. Greene,et al.  p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1* , 2004, Journal of Biological Chemistry.

[12]  M. Hung,et al.  Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. , 2007, Molecular cell.

[13]  O. Krämer HDAC2: a critical factor in health and disease. , 2009, Trends in pharmacological sciences.

[14]  Stephanie Spange,et al.  Acetylation of non-histone proteins modulates cellular signalling at multiple levels. , 2009, The international journal of biochemistry & cell biology.

[15]  Vinay Tergaonkar,et al.  NFκB pathway: A good signaling paradigm and therapeutic target , 2006 .

[16]  Myriam Alcalay,et al.  Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells , 2009, Nature.

[17]  Z. Cheng,et al.  Cell fate decision mediated by p53 pulses , 2009, Proceedings of the National Academy of Sciences.

[18]  G. Wahl,et al.  p53 stabilization is decreased upon NFκB activation , 2002 .

[19]  R. Stauber,et al.  Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis , 2008, Oncogene.

[20]  F. Weih,et al.  RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.

[21]  S. Gerondakis,et al.  The Nuclear Factor-κB and p53 Pathways Function Independently in Primary Cells and Transformed Fibroblasts Responding to Genotoxic Damage , 2008, Molecular Cancer Research.

[22]  Manuel Serrano,et al.  The common biology of cancer and ageing , 2007, Nature.

[23]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[24]  Jiandong Chen,et al.  Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53* , 2002, The Journal of Biological Chemistry.

[25]  N. Perkins,et al.  Transcriptional cross talk between NF-kappaB and p53. , 1999, Molecular and cellular biology.

[26]  K. Vousden,et al.  Role of NF-kappaB in p53-mediated programmed cell death. , 2000, Nature.

[27]  C. Prives,et al.  p53 accumulates but is functionally impaired when DNA synthesis is blocked. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  I. Petersen,et al.  Nuclear export is essential for the tumor‐promoting activity of survivin , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  V. Rotter,et al.  Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. , 2007, Cancer research.

[30]  M. Karin Nuclear factor-κB in cancer development and progression , 2006, Nature.

[31]  N. Perkins,et al.  Regulation of p53 tumour suppressor target gene expression by the p52 NF‐κB subunit , 2006, The EMBO journal.

[32]  N. Perkins,et al.  Transcriptional Cross Talk between NF-κB and p53 , 1999, Molecular and Cellular Biology.

[33]  Michael B Yaffe,et al.  p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. , 2007, Cancer cell.

[34]  J. Tschopp,et al.  Signals from within: the DNA-damage-induced NF-kappaB response. , 2006, Cell death and differentiation.

[35]  N. Mukaida,et al.  IFN-γ Protects Cerulein-Induced Acute Pancreatitis by Repressing NF-κB Activation1 , 2007, The Journal of Immunology.

[36]  D. Saur,et al.  IKKα controls p52/RelB at the skp2 gene promoter to regulate G1‐ to S‐phase progression , 2006, The EMBO journal.

[37]  M. Scian,et al.  Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression , 2005, Molecular and Cellular Biology.

[38]  L. O’Neill,et al.  Diversity and regulation in the NF-kappaB system. , 2007, Trends in biochemical sciences.

[39]  M. Karin Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[40]  R. Stauber,et al.  Acetylation of Stat1 modulates NF-kappaB activity. , 2006, Genes & development.

[41]  C. Subramanian,et al.  Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma. , 2006, Neoplasia.

[42]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[43]  K. Roemer,et al.  Inhibition of p53 protects liver tissue against endotoxin‐induced apoptotic and necrotic cell death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  C. Schoch,et al.  Clinical trial of valproic acid and all‐trans retinoic acid in patients with poor‐risk acute myeloid leukemia , 2005, Cancer.

[45]  M. Scian,et al.  Tumor-derived p53 mutants induce NF-kappaB2 gene expression. , 2005, Molecular and cellular biology.

[46]  Rinat Abramovitch,et al.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer. , 2004, Nature.

[47]  D. Saur,et al.  A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors , 2008, Proceedings of the National Academy of Sciences.

[48]  C. Arrowsmith,et al.  p53 Transcriptional Activation Domain: A Molecular Chameleon? , 2006, Cell cycle.

[49]  S. Dower,et al.  Response of tumour cells to hypoxia: role of p53 and NFkB. , 1998, Molecular pathology : MP.

[50]  Thierry Soussi,et al.  Shaping genetic alterations in human cancer: the p53 mutation paradigm. , 2007, Cancer cell.

[51]  J. Tschopp,et al.  Signals from within: the DNA-damage-induced NF-κB response , 2006, Cell Death and Differentiation.

[52]  T. Gilmore,et al.  Inhibitors of NF-kappaB signaling: 785 and counting. , 2006, Oncogene.

[53]  D. Saur,et al.  HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA , 2009, Gut.

[54]  C. Scheidereit IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. , 2006, Oncogene.

[55]  E. Boye,et al.  The multiple facets of the intra-S checkpoint , 2008, Cell cycle.

[56]  H. Kuo,et al.  Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. , 2003, Biochemical pharmacology.

[57]  A. Levine The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53. , 2009, Virology.

[58]  David A. Williams,et al.  TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. , 2007, The Journal of clinical investigation.

[59]  N. Perkins,et al.  Integrating cell-signalling pathways with NF-κB and IKK function , 2007, Nature Reviews Molecular Cell Biology.

[60]  M. Kaufman,et al.  High-frequency developmental abnormalities in p53-deficient mice , 1995, Current Biology.

[61]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[62]  V. Rotter,et al.  Cancer cells suppress p53 in adjacent fibroblasts , 2009, Oncogene.

[63]  M. Shiao,et al.  Apoptotic effect of caffeic acid phenethyl ester and its ester and amide analogues in human cervical cancer ME180 cells. , 2003, Anticancer research.

[64]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[65]  B. Aggarwal,et al.  Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Hong-Hee Kim,et al.  Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. , 2009, International immunopharmacology.

[67]  K. Vousden,et al.  Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.

[68]  L. O’Neill,et al.  Diversity and regulation in the NF-κB system , 2007 .

[69]  M. Dewhirst,et al.  Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. , 2006, Cancer research.

[70]  W. Deppert,et al.  Transcription-independent pro-apoptotic functions of p53. , 2005, Current opinion in cell biology.

[71]  V. Tergaonkar NFkappaB pathway: a good signaling paradigm and therapeutic target. , 2006, The international journal of biochemistry & cell biology.

[72]  R. Stauber,et al.  Acetylation of Stat1 modulates NF-B activity , 2006 .

[73]  L. Wiesmüller,et al.  Identification of a novel pro-apopotic function of NF-κB in the DNA damage response , 2009, Journal of cellular and molecular medicine.

[74]  W. El-Deiry,et al.  p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. , 1998, Cancer research.

[75]  W. El-Deiry,et al.  Restoration of p53 to limit tumor growth , 2008, Current opinion in oncology.

[76]  T. Gilmore,et al.  Inhibitors of NF-κB signaling: 785 and counting , 2006, Oncogene.

[77]  H. Wu,et al.  NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. , 1994, The Journal of biological chemistry.

[78]  K. Khalili,et al.  Cell cycle regulation of NF-κB-binding activity in cells from human glioblastomas , 2001 .

[79]  Somasekar Seshagiri,et al.  ATM Engages Autodegradation of the E3 Ubiquitin Ligase COP1 After DNA Damage , 2006, Science.

[80]  R. Stauber,et al.  A phosphorylation-acetylation switch regulates STAT1 signaling. , 2009, Genes & development.

[81]  A. Marusyk,et al.  Replicational Stress Selects for p53 Mutation , 2007, Cell cycle.

[82]  W. Greene,et al.  p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. , 2004, The Journal of biological chemistry.

[83]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[84]  R. Poon,et al.  Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways. , 2006, Cancer research.

[85]  F. Shanahan,et al.  Targeting the Fas/Fas ligand pathway in cancer , 2005, Expert opinion on therapeutic targets.

[86]  Nobuyuki Tanaka,et al.  p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation , 2008, Nature Cell Biology.

[87]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[88]  M. Kimmel,et al.  TNFalpha-induced activation of NFkappaB protects against UV-induced apoptosis specifically in p53-proficient cells. , 2008, Acta biochimica Polonica.

[89]  R. Wadgaonkar,et al.  CREB-binding Protein Is a Nuclear Integrator of Nuclear Factor-κB and p53 Signaling* , 1999, The Journal of Biological Chemistry.

[90]  N. Mukaida,et al.  IFN-gamma protects cerulein-induced acute pancreatitis by repressing NF-kappa B activation. , 2007, Journal of immunology.

[91]  A. Hoffmann,et al.  Immortalized fibroblasts from NF-κB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor α after transformation by v-Ras , 2005, Oncogene.

[92]  David A. Williams,et al.  TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells , 2007 .

[93]  N. Perkins,et al.  Integrating cell-signalling pathways with NF-kappaB and IKK function. , 2007, Nature reviews. Molecular cell biology.

[94]  N. Tanaka,et al.  Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation. , 2008, Biochemical and biophysical research communications.

[95]  M. Hung,et al.  Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB , 2007 .